Natixis Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $96.2M | Buy |
2,006,551
+666,676
| +50% | +$28.6M | 0.11% | 177 |
|
|
2026
Q1 | $49.2M | Sell |
1,339,875
-1,321,363
| -50% | -$62.6M | 0.07% | 276 |
|
|
2025
Q4 | $135M | Buy |
2,661,238
+105,703
| +4% | +$5.41M | 0.19% | 118 |
|
|
2025
Q3 | $142M | Sell |
2,555,535
-277,536
| -10% | -$16.2M | 0.21% | 108 |
|
|
2025
Q2 | $196M | Sell |
2,833,071
-81,033
| -3% | -$5.51M | 0.31% | 62 |
|
|
2025
Q1 | $202M | Sell |
2,914,104
-109,909
| -4% | -$9.08M | 0.37% | 51 |
|
|
2024
Q4 | $260M | Sell |
3,024,013
-50,863
| -2% | -$5.5M | 0.49% | 34 |
|
|
2024
Q3 | $366M | Buy |
3,074,876
+80,070
| +3% | +$10.7M | 0.71% | 19 |
|
|
2024
Q2 | $427M | Buy |
2,994,806
+846
| +0% | +$112K | 0.93% | 12 |
|
|
2024
Q1 | $384M | Sell |
2,993,960
-58,446
| -2% | -$6.96M | 0.88% | 13 |
|
|
2023
Q4 | $316M | Buy |
3,052,406
+55,333
| +2% | +$5.47M | 0.83% | 13 |
|
|
2023
Q3 | $273M | Sell |
2,997,073
-58,095
| -2% | -$5.12M | 0.83% | 12 |
|
|
2023
Q2 | $247M | Buy |
3,055,168
+43,960
| +1% | +$3.59M | 0.76% | 16 |
|
|
2023
Q1 | $240M | Buy |
3,011,208
+94,554
| +3% | +$6.7M | 0.82% | 11 |
|
|
2022
Q4 | $197M | Sell |
2,916,654
-51,186
| -2% | -$3M | 0.75% | 11 |
|
|
2022
Q3 | $148M | Buy |
2,967,840
+150,996
| +5% | +$8.09M | 0.63% | 18 |
|
|
2022
Q2 | $157M | Buy |
2,816,844
+405,290
| +17% | +$22.5M | 0.69% | 14 |
|
|
2022
Q1 | $134M | Buy |
2,411,554
+381,426
| +19% | +$19.6M | 0.51% | 32 |
|
|
2021
Q4 | $114M | Sell |
2,030,128
-549,576
| -21% | -$29.8M | 0.43% | 47 |
|
|
2021
Q3 | $124M | Buy |
2,579,704
+627,170
| +32% | +$30.3M | 0.51% | 35 |
|
|
2021
Q2 | $81.8M | Sell |
1,952,534
-36,512
| -2% | -$1.42M | 0.38% | 49 |
|
|
2021
Q1 | $67M | Buy |
1,989,046
+130,660
| +7% | +$4.65M | 0.35% | 55 |
|
|
2020
Q4 | $64.9M | Sell |
1,858,386
-240,692
| -11% | -$8.32M | 0.37% | 53 |
|
|
2020
Q3 | $72.9M | Sell |
2,099,078
-48,916
| -2% | -$1.63M | 0.46% | 43 |
|
|
2020
Q2 | $70.3M | Sell |
2,147,994
-879,250
| -29% | -$28.1M | 0.47% | 38 |
|
|
2020
Q1 | $91.1M | Sell |
3,027,244
-397,692
| -12% | -$11.8M | 0.74% | 22 |
|
|
2019
Q4 | $99.1M | Sell |
3,424,936
-135,408
| -4% | -$3.75M | 0.7% | 21 |
|
|
2019
Q3 | $92M | Sell |
3,560,344
-136,658
| -4% | -$3.46M | 0.73% | 20 |
|
|
2019
Q2 | $94.3M | Buy |
3,697,002
+10,974
| +0.3% | +$271K | 0.77% | 17 |
|
|
2019
Q1 | $96.4M | Buy |
3,686,028
+121,604
| +3% | +$2.99M | 0.84% | 14 |
|
|
2018
Q4 | $82.1M | Buy |
3,564,424
+3,704
| +0.1% | +$82.3K | 0.81% | 21 |
|
|
2018
Q3 | $83.9M | Buy |
3,560,720
+499,644
| +16% | +$12.2M | 0.74% | 18 |
|
|
2018
Q2 | $70.6M | Sell |
3,061,076
-415,640
| -12% | -$9.88M | 0.67% | 19 |
|
|
2018
Q1 | $85.6M | Sell |
3,476,716
-50,108
| -1% | -$1.32M | 0.85% | 16 |
|
|
2017
Q4 | $94.6M | Buy |
3,526,824
+106,376
| +3% | +$2.71M | 0.96% | 12 |
|
|
2017
Q3 | $82.3M | Buy |
3,420,448
+328,742
| +11% | +$7.43M | 0.87% | 16 |
|
|
2017
Q2 | $66.3M | Buy |
3,091,706
+89,896
| +3% | +$1.81M | 0.72% | 20 |
|
|
2017
Q1 | $51.5M | Buy |
3,001,810
+631,046
| +27% | +$11M | 0.57% | 31 |
|
|
2016
Q4 | $42.5M | Buy |
2,370,764
+364,288
| +18% | +$6.6M | 0.51% | 37 |
|
|
2016
Q3 | $41.7M | Buy |
2,006,476
+200,582
| +11% | +$4.97M | 0.54% | 36 |
|
|
2016
Q2 | $48.6M | Buy |
1,805,894
+36,378
| +2% | +$998K | 0.67% | 27 |
|
|
2016
Q1 | $47.9M | Buy |
1,769,516
+123,946
| +8% | +$3.32M | 0.72% | 22 |
|
|
2015
Q4 | $47.8M | Buy |
1,645,570
+13,134
| +0.8% | +$364K | 0.78% | 16 |
|
|
2015
Q3 | $44.3M | Buy |
1,632,436
+221,204
| +16% | +$6.26M | 0.77% | 19 |
|
|
2015
Q2 | $38.6M | Buy |
1,411,232
+169,712
| +14% | +$4.77M | 0.66% | 19 |
|
|
2015
Q1 | $33.1M | Buy |
1,241,520
+274,742
| +28% | +$6.33M | 0.58% | 20 |
|
|
2014
Q4 | $20.5M | Buy |
966,778
+244,032
| +34% | +$5.45M | 0.38% | 37 |
|
|
2014
Q3 | $17.2M | Sell |
722,746
-456,006
| -39% | -$10.5M | 0.35% | 41 |
|
|
2014
Q2 | $27.2M | Buy |
1,178,752
+74,736
| +7% | +$1.65M | 0.39% | 27 |
|
|
2014
Q1 | $25.2M | Buy |
1,104,016
+696,886
| +171% | +$14.8M | 0.39% | 30 |
|
|
2013
Q4 | $1.5M | Sell |
407,130
-22,430
| -5% | -$391K | 0.02% | 645 |
|
|
2013
Q3 | $7.27M | Buy |
429,560
+11,700
| +3% | +$197K | 0.13% | 258 |
|
|
2013
Q2 | $6.47M | Buy |
+417,860
| New | +$6.95M | 0.13% | 276 |
|
Other funds holding NVO
F
Natixis Advisors's NVO Position: Q2 2026 in Review
Natixis Advisors increased its Novo Nordisk (NVO) stake by 50% in Q2 2026, buying an estimated $28.6M and bringing the position to 2,006,551 shares worth $96.2M. The position accounts for 0.11% of the portfolio, ranked #177.
Natixis Advisors first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $427M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Natixis Advisors held 2,006,551 shares of Novo Nordisk worth $96.2M as of Q2 2026.
- Natixis Advisors bought 666,676 Novo Nordisk shares in Q2 2026, an estimated $28.6M.
- Novo Nordisk made up 0.11% of Natixis Advisors's portfolio in Q2 2026, its #177 holding.
- Natixis Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Natixis Advisors's Novo Nordisk position peaked at $427M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.